SCS Capital Management LLC Has $26.12 Million Stock Holdings in HCA Healthcare, Inc. $HCA

SCS Capital Management LLC boosted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 137.9% in the second quarter, HoldingsChannel reports. The institutional investor owned 68,180 shares of the company’s stock after buying an additional 39,524 shares during the quarter. SCS Capital Management LLC’s holdings in HCA Healthcare were worth $26,120,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Saudi Central Bank purchased a new position in HCA Healthcare during the first quarter worth about $26,000. WPG Advisers LLC bought a new position in shares of HCA Healthcare in the first quarter valued at approximately $27,000. Ameriflex Group Inc. purchased a new position in HCA Healthcare in the second quarter valued at approximately $27,000. Chung Wu Investment Group LLC bought a new stake in HCA Healthcare in the 2nd quarter valued at about $27,000. Finally, Clearstead Trust LLC boosted its position in HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after purchasing an additional 53 shares during the period. 62.73% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently commented on HCA shares. Oppenheimer upped their price target on shares of HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a research note on Monday, October 27th. TD Cowen raised their price target on HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a report on Monday, October 27th. Morgan Stanley set a $425.00 price target on HCA Healthcare in a research report on Monday, October 27th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $474.53.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.30% of the stock is owned by company insiders.

HCA Healthcare Trading Up 0.2%

Shares of HCA opened at $487.71 on Friday. The stock has a 50-day moving average price of $458.64 and a 200-day moving average price of $409.37. The company has a market cap of $111.29 billion, a PE ratio of 18.85, a price-to-earnings-growth ratio of 1.44 and a beta of 1.36. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $520.00.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the previous year, the company earned $4.90 EPS. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.